18F-fluoro-ethyl-tyrosine positron emission tomography for grading and estimation of prognosis in patients with intracranial gliomas

European Journal of Radiology

Volumn 84, Issue 5, 2015, Pages 955-962

  Gempt, Jens ^a   Bette, Stefanie ^a   Ryang, Yu Mi ^a   Buchmann, Niels ^a   Peschke, Patrick ^a   Pyka, Thomas ^a   Wester, Hans Jürgen ^a   Förster, Stefan ^a   Meyer, Bernhard ^a   Ringel, Florian ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Brain tumor surgery; FET PET; Glioblastoma; Glioma; MRI; Survival

Indexed keywords

FLUOROETHYLTYROSINE F18; TRACER; UNCLASSIFIED DRUG; O-(2-FLUOROETHYL)TYROSINE; RADIOPHARMACEUTICAL AGENT; TYROSINE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CONTRAST ENHANCEMENT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; GLIOMA; HISTOPATHOLOGY; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PET-CT SCANNER; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ANALOGS AND DERIVATIVES; AREA UNDER THE CURVE; BRAIN TUMOR; DIAGNOSTIC USE; FEMALE; FOLLOW UP; MALE; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SCINTISCANNING;

ADULT; AGED; AREA UNDER CURVE; BRAIN NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; ROC CURVE; TYROSINE;

EID: 84927567188     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2015.01.022     Document Type: Article

References (33)

1. D.N. Louis, H. Ohgaki, O.D. Wiestler, W.K. Cavenee, P.C. Burger, and A. Jouvet The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol 114 2 2007 97 109
2. J.K. Wiencke, S. Zheng, N. Jelluma, T. Tihan, S. Vandenberg, and T. Tamguney Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma Neuro Oncol 9 3 2007 271 279
3. H. Ohgaki, and P. Kleihues Genetic pathways to primary and secondary glioblastoma Am J Pathol 170 5 2007 1445 1453
4. D.R. Johnson, P.D. Brown, E. Galanis, and J.E. Hammack Pilocytic astrocytoma survival in adults: analysis of the surveillance, epidemiology, and end results program of the National Cancer Institute J Neurooncol 108 1 2012 187 193
5. K.M. Tibbetts, R.J. Emnett, F. Gao, A. Perry, D.H. Gutmann, and J.R. Leonard Histopathologic predictors of pilocytic astrocytoma event-free survival Acta Neuropathol 117 6 2009 657 665
6. C. Burkhard, P.L. Di Patre, D. Schuler, G. Schuler, M.G. Yasargil, and Y. Yonekawa A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma J Neurosurg 98 6 2003 1170 1174
7. H. Shimizu, T. Kumabe, R. Shirane, and T. Yoshimoto Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas AJNR Am J Neuroradiol 21 4 2000 659 665
8. M. Kunz, N. Thon, S. Eigenbrod, C. Hartmann, R. Egensperger, and J. Herms Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas Neuro Oncol 13 3 2011 307 316
9. M. Utriainen, M. Komu, V. Vuorinen, P. Lehikoinen, P. Sonninen, and T. Kurki Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS J Neurooncol 62 3 2003 329 338
10. J.N. Scott, P.M. Brasher, R.J. Sevick, N.B. Rewcastle, and P.A. Forsyth How often are nonenhancing supratentorial gliomas malignant? A population study Neurology 59 6 2002 947 949
11. I.M. Burtscher, G. Skagerberg, B. Geijer, E. Englund, F. Stahlberg, and S. Holtas Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings AJNR Am J Neuroradiol 21 1 2000 84 93
12. S. Sood, A. Gupta, and A.J. Tsiouris Advanced magnetic resonance techniques in neuroimaging: diffusion, spectroscopy, and perfusion Semin Roentgenol 45 2 2010 137 146
13. 18F]fluoroethyl)-l-tyrosine (F-18 FET) PET for glioma grading: assessment of individual probability of malignancy Clin Nucl Med 36 10 2011 841 847
14. G. Popperl, F.W. Kreth, J.H. Mehrkens, J. Herms, K. Seelos, and W. Koch FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading Eur J Nucl Med Mol Imaging 34 12 2007 1933 1942
15. D.D. Langleben, and G.M. Segall PET in differentiation of recurrent brain tumor from radiation injury J Nucl Med: Off Publ Soc Nucl Med 41 11 2000 1861 1867
16. F.W. Floeth, D. Pauleit, M. Sabel, G. Stoffels, G. Reifenberger, and M.J. Riemenschneider Prognostic value of O-(2-18F-fluoroethyl)-l-tyrosine PET and MRI in low-grade glioma J Nucl Med: Off Publ Soc Nucl Med 48 4 2007 519 527
17. N.L. Jansen, B. Suchorska, V. Wenter, S. Eigenbrod, C. Schmid-Tannwald, and A. Zwergal Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients J Nucl Med: Off Publ Soc Nucl Med 55 2 2014 198 203
18. D. Croteau, L. Scarpace, D. Hearshen, J. Gutierrez, J.L. Fisher, and J.P. Rock Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma Neurosurgery 49 4 2001 823 829
19. P.S.G. Wolf, and K. Ulm The use of ROC for defining the validity of the prognostic index in censored data Stat Prob Lett 81 2011 783 791
20. U. Pichlmeier, A. Bink, G. Schackert, and W. Stummer Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients Neuro Oncol 10 6 2008 1025 1034
21. L. Khalid, M. Carone, N. Dumrongpisutikul, J. Intrapiromkul, D. Bonekamp, and P.B. Barker Imaging characteristics of oligodendrogliomas that predict grade AJNR Am J Neuroradiol 33 5 2012 852 857
22. M.L. Schafer, M.H. Maurer, M. Synowitz, J. Wustefeld, T. Marnitz, and F. Streitparth Low-grade (WHO II) and anaplastic (WHO III) gliomas: differences in morphology and MRI signal intensities Eur Radiol 23 10 2013 2846 2853 10.1007/s00330-013-2886-y Epub 2013 May 19
23. R. Sanz-Requena, A. Revert-Ventura, L. Martí-Bonmatí, A. Alberich-Bayarri, and G. García-Martí Quantitative MR perfusion parameters related to survival time in high-grade gliomas Eur Radiol 23 12 2013 3456 3465 10.1007/s00330-013-2967-y Epub 2013 Jul 10
24. 1H-magnetic resonance spectroscopy chemical shift imaging for detection of anaplastic foci in diffusely infiltrating gliomas with non-significant contrast-enhancement J Neurol Neurosurg Psychiatry 82 5 2011 512 520
25. F. Thiele, J. Ehmer, M.D. Piroth, M.J. Eble, H.H. Coenen, and H.J. Kaiser The quantification of dynamic FET PET imaging and correlation with the clinical outcome in patients with glioblastoma Phys Med Biol 54 18 2009 5525 5539
26. 18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas Neurosurgery 57 3 2005 505 511 Discussion-11
27. 18F-FDG PET images for brain tumor identification and delineation J Nucl Med: Off Publ Soc Nucl Med 52 6 2011 865 872
28. M. Plotkin, C. Blechschmidt, G. Auf, F. Nyuyki, L. Geworski, and T. Denecke Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas Eur Radiol 20 10 2010 2496 2502
29. S. Okamoto, T. Shiga, N. Hattori, N. Kubo, T. Takei, and N. Katoh Semiquantitative analysis of C-11 methionine PET may distinguish brain tumor recurrence from radiation necrosis even in small lesions Ann Nucl Med 25 3 2011 213 220
30. 18F-fluoroethyl)-l-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma J Nucl Med: Off Publ Soc Nucl Med 52 6 2011 856 864
31. C. la Fougere, B. Suchorska, P. Bartenstein, F.W. Kreth, and J.C. Tonn Molecular imaging of gliomas with PET: opportunities and limitations Neuro Oncol 13 8 2011 806 819
32. 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma J Nucl Med: Off Publ Soc Nucl Med 54 2 2013 229 235
33. N.L. Jansen, C. Schwartz, V. Graute, S. Eigenbrod, J. Lutz, and R. Egensperger Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas Neuro Oncol 14 12 2012 1473 1480